BALPHARMA.NS
Bal Pharma Limited
NSEINREQUITY
Healthcare
DELAYED
Buy
+31/100
Last price
97.70
▼ 0.92 (0.93%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
100.59
Prev close
98.62
Day high
100.59
Day low
96.05
Volume
12.29K
Market cap
$1.56B
P/E (TTM)
20.92
52W range
60.00 – 124.60
Day trading desk
Gap from prior close
-0.86%
Prior close 101.46
VWAP
98.59
-0.90% from price
Relative volume
0.13×
Quiet session
Session range
4.73%
96.05 – 100.59
Position in range
36%
Mid range
ATR (14D)
6.12
6.26% of price
Prior day high
105.00
PDH
Prior day low
101.46
PDL
Bid / ask spread
—
Quote not published
Session volume
10.10K
Avg 78.32K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-12.85%
-14.8%
1M
+11.36%
+9.9%
3M
+26.62%
+23.2%
6M
+29.01%
+14.0%
YTD
+33.25%
+19.3%
1Y
+17.82%
+2.1%
3Y
+3.06%
-78.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BALPHARMA.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
10.33M
Total on file
Fundamentals
Market cap$1.56B
Enterprise value$3.06B
Revenue (TTM)$3.34B
Gross profit$1.59B
EBITDA$348.60M
Net income$72.06M
EPS (TTM)$4.67
Free cash flow—
Total cash$92.92M
Total debt$1.60B
Book value / share$51.71
Shares outstanding15.92M
Float5.42M
Short % of float—
Dividend yield1.22%
Beta (5Y)0.44
Valuation & profitability ratios
Trailing P/E20.92
Forward P/E—
PEG ratio—
Price / sales—
Price / book1.89
EV / revenue0.92
EV / EBITDA8.79
Gross margin47.50%
Operating margin5.83%
Profit margin2.15%
Return on equity—
Return on assets—
Debt / equity193.94
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $3.03B | $2.94B | $3.39B | $3.02B | — | +3.0% |
| Operating revenue | $3.03B | $2.94B | $3.26B | $3.02B | — | +3.0% |
| Cost of revenue | $1.62B | $1.61B | $1.95B | $1.76B | — | +0.5% |
| Gross profit | $1.41B | $1.33B | $1.31B | $1.25B | — | +5.9% |
| Research & development | — | — | — | $0 | $0 | — |
| Selling, general & admin | $220.24M | $240.13M | $220.74M | $181.98M | — | -8.3% |
| Total operating expense | $1.18B | $1.13B | $1.09B | $1.08B | — | +4.4% |
| Operating income | $229.16M | $201.01M | $217.75M | $175.45M | — | +14.0% |
| Net interest income | -$160.71M | -$160.54M | -$141.06M | -$120.83M | — | -0.1% |
| Pre-tax income | $59.34M | $51.37M | $90.47M | $47.48M | — | +15.5% |
| Tax provision | -$3.86M | -$20.99M | $16.02M | $21.29M | — | +81.6% |
| Net income | $62.84M | $72.15M | $73.92M | $25.72M | — | -12.9% |
| Net income to common | $62.84M | $72.15M | $73.92M | $25.72M | — | -12.9% |
| Basic EPS | 3.95 | 4.56 | 4.96 | 1.67 | — | -13.4% |
| Diluted EPS | 3.95 | 4.56 | 4.96 | 1.67 | — | -13.4% |
| EBIT | $208.16M | $196.76M | $219.52M | $152.44M | — | +5.8% |
| EBITDA | $318.96M | $294.47M | $336.01M | $243.73M | — | +8.3% |
| Basic shares | 15.92M | 15.85M | 15.74M | 15.69M | — | +0.4% |
| Diluted shares | 15.92M | 15.85M | 15.74M | 15.69M | — | +0.4% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $23.01M | $17.52M | $41.96M | $14.87M | +31.4% |
| Cash & short-term investments | $92.08M | $104.10M | $199.29M | $74.63M | -11.6% |
| Accounts receivable | $936.33M | $924.43M | $996.22M | $939.76M | +1.3% |
| Inventory | $1.16B | $1.03B | $878.12M | $980.05M | +12.9% |
| Total current assets | $2.62B | $2.35B | $2.34B | $2.28B | +11.6% |
| Property, plant & equipment | $852.42M | $753.66M | $669.60M | $641.99M | +13.1% |
| Goodwill & intangibles | $172.49M | $158.24M | $152.08M | $142.86M | +9.0% |
| Total assets | $3.76B | $3.36B | $3.20B | $3.13B | +11.9% |
| Total current liabilities | $2.49B | $2.20B | $2.03B | $2.09B | +13.5% |
| Current debt | $1.28B | $1.19B | $1.03B | $1.00B | +7.3% |
| Long-term debt | $318.85M | $314.13M | $363.49M | $305.23M | +1.5% |
| Total debt | $1.67B | $1.50B | $1.42B | $1.33B | +10.8% |
| Total liabilities | $2.93B | $2.58B | $2.48B | $2.49B | +13.6% |
| Retained earnings | $316.83M | $273.10M | $220.52M | $146.89M | +16.0% |
| Shareholder equity | $822.27M | $774.16M | $720.04M | $637.89M | +6.2% |
| Working capital | $130.06M | $153.72M | $311.04M | $188.22M | -15.4% |
| Net tangible assets | $649.78M | $615.91M | $567.96M | $495.04M | +5.5% |
| Shares issued | 15.92M | 15.92M | 15.80M | 15.69M | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $59.34M | $51.37M | $90.47M | $47.48M | +15.5% |
| Depreciation & amortisation | $110.79M | $97.71M | $100.71M | $91.28M | +13.4% |
| Stock-based compensation | $0 | $0 | $0 | $0 | — |
| Change in working capital | -$16.39M | -$74.89M | -$40.43M | -$275.25M | +78.1% |
| Operating cash flow | $308.35M | $203.15M | $228.06M | -$15.37M | +51.8% |
| Capital expenditure | -$223.80M | -$187.87M | -$109.80M | -$146.45M | -19.1% |
| Investing cash flow | -$206.99M | -$149.17M | -$188.91M | -$221.82M | -38.8% |
| Share buybacks | -$1.00K | — | — | — | — |
| Dividends paid | -$19.11M | -$19.11M | -$15.69M | -$15.57M | 0.0% |
| Financing cash flow | -$95.86M | -$78.42M | -$12.06M | $240.94M | -22.2% |
| Free cash flow | $84.55M | $15.28M | $118.26M | -$161.82M | +453.3% |
| End cash position | $23.01M | $17.52M | $41.96M | $14.87M | +31.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $886.16M | $840.76M | $876.90M | $740.25M | $658.71M | +5.4% |
| Operating revenue | $886.16M | $840.76M | $876.90M | $740.25M | $658.71M | +5.4% |
| Cost of revenue | $511.52M | $383.27M | $461.60M | $399.35M | $335.43M | +33.5% |
| Gross profit | $374.64M | $457.49M | $415.30M | $340.90M | $323.28M | -18.1% |
| Total operating expense | $322.99M | $382.39M | $352.15M | $306.30M | $287.89M | -15.5% |
| Operating income | $51.66M | $75.09M | $63.15M | $34.59M | $35.40M | -31.2% |
| Net interest income | -$44.66M | -$40.55M | -$48.50M | -$38.58M | -$40.53M | -10.1% |
| Pre-tax income | $11.38M | $32.17M | $17.91M | $7.17M | $2.08M | -64.6% |
| Tax provision | $0 | -$3.86M | $0 | $0 | $0 | +100.0% |
| Net income | $11.23M | $35.94M | $17.80M | $7.09M | $2.01M | -68.7% |
| Net income to common | $11.23M | $35.94M | $17.80M | $7.09M | $2.01M | -68.7% |
| Basic EPS | 0.71 | 2.26 | 1.12 | 0.45 | 0.13 | -68.6% |
| Diluted EPS | 0.71 | 2.26 | 1.12 | 0.45 | 0.13 | -68.6% |
| EBIT | $56.04M | $72.73M | $66.41M | $45.75M | $42.62M | -23.0% |
| EBITDA | $83.86M | $103.31M | $98.71M | $68.46M | $67.82M | -18.8% |
| Basic shares | 15.82M | 15.90M | 15.89M | 15.77M | 15.43M | -0.5% |
| Diluted shares | 15.82M | 15.90M | 15.89M | 15.77M | 15.43M | -0.5% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $23.01M | $15.81M | $17.52M | +45.6% |
| Cash & short-term investments | $92.08M | $106.56M | $104.10M | -13.6% |
| Accounts receivable | $936.33M | $908.24M | $924.43M | +3.1% |
| Inventory | $1.16B | $1.13B | $1.03B | +3.3% |
| Total current assets | $2.62B | $2.45B | $2.35B | +7.0% |
| Property, plant & equipment | $852.42M | $792.06M | $753.66M | +7.6% |
| Goodwill & intangibles | $172.49M | $162.92M | $158.24M | +5.9% |
| Total assets | $3.76B | $3.49B | $3.36B | +7.5% |
| Total current liabilities | $2.49B | $2.29B | $2.20B | +8.9% |
| Current debt | $1.28B | $1.24B | $1.19B | +3.3% |
| Long-term debt | $318.85M | $313.67M | $314.13M | +1.7% |
| Total debt | $1.67B | $1.55B | $1.52B | +7.6% |
| Total liabilities | $2.93B | $2.71B | $2.58B | +8.2% |
| Retained earnings | $316.83M | — | $273.10M | — |
| Shareholder equity | $822.27M | $783.26M | $774.16M | +5.0% |
| Working capital | $130.06M | $161.13M | $153.72M | -19.3% |
| Net tangible assets | $649.78M | $620.34M | $615.91M | +4.7% |
| Shares issued | 15.92M | 15.92M | 15.92M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders65.28%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
105.91
-7.75% from price
SMA 20
105.60
-7.48% from price
SMA 50
94.51
+3.38% from price
SMA 100
89.92
+8.65% from price
SMA 200
81.45
+19.95% from price
EMA 12
104.20
-6.24% from price
EMA 26
101.38
-3.63% from price
EMA 50
96.75
+0.98% from price
RSI (14)
45.9
Neutral
MACD (12,26,9)
2.81
Hist -1.39
ATR (14)
6.12
6.26% of price
Realised vol 30D
75.1%
Annualised
Bollinger upper
114.70
20, 2σ
Bollinger lower
96.50
20, 2σ
50 / 200 cross
Golden
94.51 vs 81.45
Trend bias
Above 200
+19.95%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.06
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
75.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.9%
Peak to trough
Max drawdown 5Y
-60.4%
Peak to trough
ATR 14
6.12
6.26% of price
Beta (reported)
0.44
5Y monthly, from filing
Dividends & splits
Forward rate$1.20 / yr
Forward yield1.22%
5-year avg yield1.10%
Payout ratio26.43%
Ex-dividend dateSep 17, 2026
Next pay date—
Last split—
Split date—
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.